Alphabet Inc’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Hold |
640,882
| – | – | 0.07% | 27 |
|
|
2025
Q1 | $891K | Hold |
640,882
| – | – | 0.06% | 31 |
|
|
2024
Q4 | $1.11M | Hold |
640,882
| – | – | 0.06% | 30 |
|
|
2024
Q3 | $1.29M | Hold |
640,882
| – | – | 0.07% | 31 |
|
|
2024
Q2 | $1.44M | Hold |
640,882
| – | – | 0.07% | 33 |
|
|
2024
Q1 | $1.84M | Hold |
640,882
| – | – | 0.07% | 32 |
|
|
2023
Q4 | $1.13M | Hold |
640,882
| – | – | 0.05% | 36 |
|
|
2023
Q3 | $2.03M | Hold |
640,882
| – | – | 0.13% | 30 |
|
|
2023
Q2 | $423K | Hold |
640,882
| – | – | 0.02% | 40 |
|
|
2023
Q1 | $513K | Hold |
640,882
| – | – | 0.03% | 41 |
|
|
2022
Q4 | $1.45M | Hold |
640,882
| – | – | 0.08% | 40 |
|
|
2022
Q3 | $1.24M | Hold |
640,882
| – | – | 0.06% | 42 |
|
|
2022
Q2 | $2.38M | Hold |
640,882
| – | – | 0.13% | 39 |
|
|
2022
Q1 | $4.18M | Hold |
640,882
| – | – | 0.14% | 40 |
|
|
2021
Q4 | $7.47M | Hold |
640,882
| – | – | 0.18% | 38 |
|
|
2021
Q3 | $11.9M | Hold |
640,882
| – | – | 0.28% | 28 |
|
|
2021
Q2 | $13.6M | Hold |
640,882
| – | – | 0.28% | 24 |
|
|
2021
Q1 | $13M | Hold |
640,882
| – | – | 0.52% | 21 |
|
|
2020
Q4 | $17M | Hold |
640,882
| – | – | 0.82% | 17 |
|
|
2020
Q3 | $14.4M | Buy |
+640,882
| New | +$14.4M | 0.67% | 11 |
|